You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial
|
---|---|
Published in |
Breast Cancer Research, September 2019
|
DOI | 10.1186/s13058-019-1195-z |
Pubmed ID | |
Authors |
Barbara Adamo, Meritxell Bellet, Laia Paré, Tomás Pascual, Maria Vidal, José A. Pérez Fidalgo, Salvador Blanch, Noelia Martinez, Laura Murillo, Patricia Gómez-Pardo, Ana López-González, Kepa Amillano, Jordi Canes, Patricia Galván, Blanca González-Farré, Xavier González, Patricia Villagrasa, Eva Ciruelos, Aleix Prat |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 16 | 42% |
United States | 2 | 5% |
Brazil | 1 | 3% |
Italy | 1 | 3% |
Switzerland | 1 | 3% |
Russia | 1 | 3% |
Egypt | 1 | 3% |
Japan | 1 | 3% |
Unknown | 14 | 37% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 23 | 61% |
Practitioners (doctors, other healthcare professionals) | 9 | 24% |
Scientists | 5 | 13% |
Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 76 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 13% |
Student > Master | 8 | 11% |
Student > Bachelor | 8 | 11% |
Other | 5 | 7% |
Student > Ph. D. Student | 3 | 4% |
Other | 12 | 16% |
Unknown | 30 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 22% |
Nursing and Health Professions | 6 | 8% |
Biochemistry, Genetics and Molecular Biology | 5 | 7% |
Computer Science | 2 | 3% |
Immunology and Microbiology | 2 | 3% |
Other | 6 | 8% |
Unknown | 38 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2021.
All research outputs
#1,398,277
of 25,385,509 outputs
Outputs from Breast Cancer Research
#113
of 2,054 outputs
Outputs of similar age
#29,568
of 353,365 outputs
Outputs of similar age from Breast Cancer Research
#2
of 23 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,054 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,365 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.